Al Jazeera: could daily GLP-1 pills widen diabetes and obesity treatment in the Global South?
_Image credit: Al Jazeera_
Al Jazeera explains how GLP-1 treatment is moving from weekly jabs such as Ozempic, Wegovy and Mounjaro to once-daily pills. It asks whether tablets, which are easier to store and distribute, could make these medicines more accessible in lower-income countries where one in nine people worldwide live with diabetes.
Source: Al Jazeera (14 Nov 2026). Image: Al Jazeera.